<DOC>
	<DOCNO>NCT02708394</DOCNO>
	<brief_summary>This study investigate molecular mechanism atypical-antipsychotic induced insulin resistance . This accomplish administer olanzapine placebo healthy subject 7 day analyze genetic protein change peripheral tissue know play important role insulin resistance pathophysiology .</brief_summary>
	<brief_title>Molecular Mechanisms Antipsychotic-induced Insulin Resistance</brief_title>
	<detailed_description />
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<criteria>We include person meet follow criterion : 1 . 2145 year old 2 . BMI 18.524.9kg/m2 3 . No history drug alcohol dependence abuse 4 . No current past history psychiatric neurologic disease 5. minimal exercise routine prior study ( light walk allow ) 6 . Normal liver function test 7 ) minimal alcohol intake ( &lt; 1 drink per day ) . The following person exclude : 1 . Has 1st degree relative diabetes ( I II ) 2. current recent nicotine intake 3. presence organic/physical disease could affect glucose 4. currently take prescription overthecounter medication could affect glucose 5. currently pregnant lactate 6. unwilling take acceptable birth control method 7. current previous exposure antipsychotic 8. history unstable weight 9. personal family history cardiac arrhythmia seizures 10. current past history eat disorder ( ) restrict diet 11. allergy lidocaine drug excipients 12. history difficulty intravenous line placement 13. history fainting .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>